Degan Lu
Degan Lu
Jinan, Shandong, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Enrolling by invitation | Not stated | 2025-03-19 | NCT06883136 | |
| Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance | Advanced Non-small Cell Lung Cancer | Recruiting | Phase 3 | 2023-09-21 | NCT06043973 |